s6y
Company name or ticker
Search
Bassler Bonnie L
4
REGENERON PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
Filed
Friday, April 1, 2022
Period
Mar 30, 2022
Accession number
0001883850-22-000030
Documents
PRIMARY DOCUMENT
4
On sec.gov
Filing index
All files
Complete submission text
SGML header